Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Risk management and regulations for lower limb medical exoskeletons: a review.

PMID: 28533700 ·

Y, o, n, g, t, i, a, n, , H, e, ;, , D, a, v, i, d, , E, g, u, r, e, n, ;, , T, r, i, e, u, , P, h, a, t, , L, u, u, ;, , J, o, s, e, , L, , C, o, n, t, r, e, r, a, s, -, V, i, d, a, l

RevistaMedical devices (Auckland, N.Z.)
Ano
PMID28533700

Resumo

Gait disability is a major health care problem worldwide. Powered exoskeletons have recently emerged as devices that can enable users with gait disabilities to ambulate in an upright posture, and potentially bring other clinical benefits. In 2014, the US Food and Drug Administration approved marketing of the ReWalk™ Personal Exoskeleton as a class II medical device with special controls. Since then, Indego™ and Ekso™ have also received regulatory approval. With similar trends worldwide, this ind

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑